Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Ginkgo Bioworks Holdings Inc DNA

Alternate Symbol(s):  DNABW

Healthcare Biotechnology
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops a platform for cell engineering in the United States. It operates through the Cell Engineering and Biosecurity segments. The company offers cell engineering research and development solutions, as well as cell engineering tools comprising functional genomics, antibody developability, and small molecule developability... see more

Current News (NYSE:DNA)

Ginkgo Bioworks partners on Deep Origin-led team to develop new tools for predicting drug safety

PR Newswire December 9, 2025

Ginkgo Bioworks Selected by PNNL to Deliver a Modular, High‑Throughput Phenotyping Platform for DOE's M2PC

PR Newswire December 5, 2025

STRM.BIO Awarded ARPA-H Contract to Advance Megakaryocyte-Derived Vesicle Platform for In Vivo Cell Engineering and Gene Therapy

PR Newswire December 3, 2025

Ginkgo Bioworks Partners on Illinois-Led Team to Develop Innovative New Treatments for Oral Health

PR Newswire November 18, 2025

Ginkgo Bioworks Reports Third Quarter 2025 Financial Results

PR Newswire November 6, 2025

Ginkgo Bioworks Awarded Project Agreement through BARDA's BioMaP-Consortium

PR Newswire November 3, 2025

Ginkgo Bioworks and Bayer Extend Multi-Year Strategic Partnership to Accelerate Next Generation Biological Solutions for Agriculture

PR Newswire October 31, 2025

Ginkgo Bioworks Announces Date of Third Quarter 2025 Results Presentation

PR Newswire October 30, 2025

Ginkgo Bioworks in Partnership with STRM.BIO and University of British Columbia in Project to Develop In Vivo CAR Therapies Under ARPA-H's EMBODY Program

PR Newswire October 23, 2025
View More News ››

Opinion & Analysis (NYSE:DNA)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NYSE:DNA)

Worst investment!

Now I understood that Cathie wood is a pure gambler.... she ended her gambling in DNA and sold everything with huge loss. So the lesson...
Paray99 - July 10, 2024

AARK.

Should have been the above Ticker.  
Lookingforclues - April 25, 2024

DNA

Is this Company going anywhere? ASRK has invested heavily. Thoughts please.  Ty.
Lookingforclues - April 25, 2024

AI!

That's their only news.......wow
Lookingforclues - November 15, 2023

U r Joking,

Its 2 Bucks!
Lookingforclues - November 15, 2023

When is that big swan event happening?

My target selling price for DNA is $20... when is that coming?
Paray99 - September 16, 2023
View more Bullboard ››

Viridian Metals Inc.

Viridian Metals Inc.

Viridian Metals Inc. is a Canadian company engaged in generative exploration for critical metals, with a primary focus on ...
View More »

Podcasts